[1] 黄伟.《第三版脓毒症与感染性休克定义国际共识》解读[J].中国实用内科杂志, 2016, 36(11):959-962.
[2] FLEISCHMANN C, SCHERAG A, ADHIKARI N K, et al.Assessment of global incidence and mortality of hospital-treated sepsis.Current estimates and limitations[J].Am J Respir Crit Care Med, 2016, 193(3):259-272.
[3] MENG Q, GUO P, JIANG Z, et al.Dexmedetomidine inhibits LPS-induced proinflammatory responses via suppressing HIF1α-dependent glycolysis in macrophages[J].Aging(Albany NY), 2020, 12(10):9534-9548.
[4] ARORA S, DEV K, AGARWAL B, et al.Macrophages:their role, activation and polarization in pulmonary diseases[J].Immunobiology, 2018, 223(4-5):383-396.
[5] PORTA C, RIMOLDI M, RAES G, et al.Tolerance and M2(alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB[J].Proc Natl Acad Sci U S A, 2009, 106(35):14978-14983.
[6] ESSANDOH K, LI Y, HUO J, et al.MiRNA-mediated macrophage polarization and its potential role in the regulation of inflammatory response[J].SHOCK, 2016, 46(2):122-131.
[7] SICA A, ERRENI M, ALLAVENA P, et al.Macrophage polarization in pathology[J].Cell Mol Life Sci, 2015, 72(21):4111-4126.
[8] FUNES S C, RIOS M, ESCOBAR-VERA J, et al.Implications of macrophage polarization in autoimmunity[J].Immunobiology, 2018, 154(2):186-195.
[9] WANG Y, SMITH W, HAO D, et al.M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds[J].Int Immunopharmacol, 2019, 70:459-466.
[10] BAI Y X, ZHANG J H, ZHAO B C, et al.Dexmedetomidine attenuates one-lung ventilation associated lung injury by suppressing inflammatory responses:a systematic review and meta-analysis[J]. Clin Exp Pharmacol Physiol, 2021, 48(9):1203-1214.
[11] WANG C, YUAN W, HU A, et al.Dexmedetomidine alleviated sepsis induced myocardial ferroptosis and septic heart injury[J].Mol Med Rep, 2020, 22(1):175-184.
[12] BISWAS S K, CHITTEZHATH M, SHALOVA I N, et al.Macrophage polarization and plasticity in health and disease[J].Immunol Res, 2012, 53(1-3):11-24.
[13] 李红霞, 翁亦齐, 喻文立, 等.右美托咪定对大鼠肝脏冷缺血再灌注诱发心肌损伤的保护作用[J].中华器官移植杂志, 2019, 40:374-378.
[14] 邓丽静, 王岚, 王波, 等.右美托咪定对脓毒症大鼠炎症反应和淋巴细胞凋亡的影响[J].中国危重病急救医学, 2012, 24:558-561.
[15] SONG Y C, LIU R, LI R H, et al.Dexmedetomidine exerts renal protective effect by regulating the PGC-1α/STAT1/IRF-1 axis[J].Nephron, 2021, 145(5):528-539.
[16] ZHANG C, LIU J, YUAN C, et al.JAK2/STAT3 is associated with the inflammatory process in periapical granuloma[J].Int J Clin Exp Pathol, 2019, 12(1):190-197.
[17] PATTISON M J, MACKENZIE K F, ARTHUR J S.Inhibition of JAKs in macrophages increases lipopolysaccharide-induced cytokine production by blocking IL-10-mediated feedback[J].J Immunol, 2012, 189(6):2784-2792.
[18] PAN S, CHEN Y, ZHANG X, et al.The JAK2/STAT3 pathway is involved in dexmedetomidine-induced myocardial protection in rats undergoing cardiopulmonary bypass[J].Ann Transl Med, 2020, 8(7):483.
[19] ZHOU H, SUN J, ZHONG W, et al.Dexmedetomidine preconditioning alleviated murine liver ischemia and reperfusion injury by promoting macrophage M2 activation via PPARγ/STAT3 signaling[J].Int Immunopharmacol, 2020, 82:106363.
[20] FUJIMOTO M, HIGUCHI H, HONDA-WAKASUGI Y, et al.Dexmedetomidine inhibits LPS-induced inflammatory responses through peroxisome proliferator-activated receptor gamma(PPARγ) activation following binding to α(2) adrenoceptors[J].Eur J Pharmacol, 2021, 892:173733.
[21] WANG S L, DUAN L, XIA B, et al.Dexmedetomidine preconditioning plays a neuroprotective role and suppresses TLR4/NF-κB pathways model of cerebral ischemia reperfusion[J].Biomed Pharmacother, 2017, 93:1337-1342.
[22] LIAO X, SHARMA N, KAPADIA F, et al.Krüppel-like factor 4 regulates macrophage polarization[J].J Clin Invest, 2011, 121(7):2736-2749.
[23] LINTON M F, MOSLEHI J J, BABAEV V R.Akt Signaling in macrophage polarization, survival, and atherosclerosis[J].Int J Mol Sci, 2019, 20(11):2703-2712.
[24] VERGADI E, IERONYMAKI E, LYRONI K, et al.Akt signaling pathway in macrophage activation and M1/M2 polarization[J].J Immunol, 2017, 198(3):1006-1014.
[25] ZHAO Y, FENG X, LI B, et al.Dexmedetomidine protects against lipopolysaccharide-induced acute kidney injury by enhancing autophagy through inhibition of the PI3K/AKT/mTOR pathway[J].Front Pharmacol, 2020, 11:128.
[26] HARDIE D G.AMP-activated protein kinase:an energy sensor that regulates all aspects of cell function[J].Genes Dev, 2011, 25(18):1895-1908.
[27] CHEN Y, HUANG Y, XIONG B, et al.Dexmedetomidine ameliorates renal ischemia reperfusion-mediated activation of the NLRP3 inflammasome in alveolar macrophages[J].GENE, 2020, 758:144973.
[28] OHASHI E, KOHNO K, ARAI N, et al.Adenosine N1-oxide exerts anti-inflammatory effects through the PI3K/Akt/GSK-3β signaling pathway and promotes osteogenic and adipocyte differentiation[J].Biol Pharm Bull, 2019, 42(6):968-976.
[29] FENG X, GUAN W, ZHAO Y, et al.Dexmedetomidine ameliorates lipopolysaccharide-induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK-3β/Nrf2 signaling pathway[J].J Cell Physiol, 2019, 234(10):18994-19009.
[30] XU Y, ZHANG R, LI C, et al.Dexmedetomidine attenuates acute lung injury induced by lipopolysaccharide in mouse through inhibition of MAPK pathway[J].Fundam Clin Pharmacol, 2015, 29(5):462-471.
[31] ISLAM S U, LEE J H, SHEHZAD A, et al.Decursinol angelate inhibits LPS-induced macrophage polarization through modulation of the NFκB and MAPK signaling pathways[J].Molecules, 2018, 23(8):1880-1887.
[32] QIU Z, LU P, WANG K, et al.Dexmedetomidine inhibits neuroinflammation by altering microglial M1/M2 polarization through MAPK/ERK pathway[J].Neurochem Res, 2020, 45(2):345-353.
[33] CHEN Y, LI L, ZHANG J, et al.Dexmedetomidine alleviates lipopolysaccharide-induced hippocampal neuronal apoptosis via inhibiting the p38 MAPK/c-Myc/CLIC4 signaling pathway in rats[J].Mol Neurobiol, 2021, 58(11):5533-5547.
[34] GUO M, HÄRTLOVA A, GIERLISKI M, et al.Triggering MSR1 promotes JNK-mediated inflammation in IL-4-activated macrophages[J].Embo J, 2019, 38(11):e100299.
[35] ZHANG X, WANG J, QIAN W, et al.Dexmedetomidine inhibits tumor necrosis factor-alpha and interleukin 6 in lipopolysaccharide-stimulated astrocytes by suppression of c-Jun N-terminal kinases[J].Inflammation, 2014, 37(3):942-949.
[36] CHU J, LI X, QU G, et al.Chlamydia psittaci PmpD-N exacerbated chicken macrophage function by triggering Th2 polarization and the TLR2/MyD88/NF-κB signaling pathway[J].Int J Mol Sci, 2020, 21(6).
[37] HU M, LI X, ZHANG J, et al.GEN-27 exhibits anti-inflammatory effects by suppressing the activation of NLRP3 inflammasome and NF-κB pathway[J].Cell Biol Int, 2019, 43(10):1184-1192.
[38] JIN Y H, LI Z T, CHEN H, et al.Effect of dexmedetomidine on kidney injury in sepsis rats through TLR4/MyD88/NF-κB/iNOS signaling pathway[J].Eur Rev Med Pharmacol Sci, 2019, 23(11):5020-5025.
[39] ZHOU X Y, LIU J, XU Z P, et al.Dexmedetomidine inhibits the lipopolysaccharide-stimulated inflammatory response in microglia through the pathway involving TLR4 and NF-κB[J].Kaohsiung J Med Sci, 2019, 35(12):750-756.
[40] 刘利萍, 张焱皓, 李茂, 等.调控巨噬细胞极化的相关信号通路及其调节机制研究进展[J].中国免疫学杂志, 2021, 37(6):747-753.
[41] HE L, WANG Z, ZHOU R, et al.Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway[J].Biomed Pharmacother, 2021, 133:110993.
[42] XU L, LI T, CHEN Q, et al.The α2AR/Caveolin-1/p38MAPK/NF-κB axis explains dexmedetomidine protection against lung injury following intestinal ischaemia-reperfusion[J].J Cell Mol Med, 2021, 25(13):6361-6372. |
